tiprankstipranks
Trending News
More News >
Avadel announces appeals court decision upholding FDA approval of LUMRYZ
PremiumThe FlyAvadel announces appeals court decision upholding FDA approval of LUMRYZ
7d ago
Jazz Pharmaceuticals and BeiGene’s Promising Phase 3 Study for Advanced Gastric and Esophageal Cancers
Premium
Company Announcements
Jazz Pharmaceuticals and BeiGene’s Promising Phase 3 Study for Advanced Gastric and Esophageal Cancers
9d ago
Jazz Pharmaceuticals’ Zanidatamab Study: A Potential Game-Changer in HER2 Cancer Treatment
Premium
Company Announcements
Jazz Pharmaceuticals’ Zanidatamab Study: A Potential Game-Changer in HER2 Cancer Treatment
9d ago
Jazz Pharmaceuticals: FDA accepts sNDA for Zepzelca/ Atezolizumab combo
PremiumThe FlyJazz Pharmaceuticals: FDA accepts sNDA for Zepzelca/ Atezolizumab combo
27d ago
Jazz Pharmaceuticals presents late-breaking phase 4 data showcasing Xywav
Premium
The Fly
Jazz Pharmaceuticals presents late-breaking phase 4 data showcasing Xywav
27d ago
Jazz Pharmaceuticals: Promising Developments and Positive Data Reinforce Buy Rating
Premium
Ratings
Jazz Pharmaceuticals: Promising Developments and Positive Data Reinforce Buy Rating
1M ago
Optimistic Buy Rating for Jazz Pharmaceuticals Amidst Short-term Challenges and Long-term Growth Potential
PremiumRatingsOptimistic Buy Rating for Jazz Pharmaceuticals Amidst Short-term Challenges and Long-term Growth Potential
2M ago
Jazz Pharmaceuticals Balances Growth and Challenges in Earnings Call
Premium
Company Announcements
Jazz Pharmaceuticals Balances Growth and Challenges in Earnings Call
2M ago
Jazz Pharmaceuticals price target lowered to $172 from $182 at RBC Capital
Premium
The Fly
Jazz Pharmaceuticals price target lowered to $172 from $182 at RBC Capital
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100